AzTrials
AzTrials

Wounds and InjuriesNCT02028390

Overlaying a Visual Wound Trace Onto Its Thermal Image in a Wound Clinic

A study testing Scout takes visual and thermal images of external wounds, ImageReview's visual perimeter trace of the external wound and ImageReview's External Wound Trace Overlay in people with Wounds and Injuries, run by Wound Vision at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to test and evaluate how well a medical imaging device that takes both visual and thermal pictures of wounds or body surface areas of interest can help collect added information about the wounds or body surface areas of interest in a wound clinic. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Wounds and Injuries
What is being tested?
Scout takes visual and thermal images of external wounds, ImageReview's visual perimeter trace of the external wound and ImageReview's External Wound Trace Overlay
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
31 participants
Where
1 siteUnited States
Study dates
Dec 2013to Mar 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age 18 or greater, of either gender and of any ethnic background
  • Able to tolerate position change(s) and turns for up to 10 minutes comfortably
  • Have an existing external wound or body surface area of interest:
  • External wound or body surface area of interest must be in separate body locations (ex: one on the right heel, one on the left heel, and the other on the sacrum)
  • Have qualifying external wound or body surface area of interest:
  • External wound or body surface area of interest that fits entirely within the field of view and does not wrap around a body edge
  • No device or treatment will obscure the external wound or body surface area of interest

Who cannot join

  • Neonatal and pediatric patients
  • Pregnant women
  • Cannot tolerate position changes for up to 10 minutes comfortably (per external wound site imaged)
  • On therapies or treatments which cannot be safely suspended long enough to conduct an imaging session as determined by facility policy
  • Have a wound dressing or medical device which cannot or should not be removed as determined by site investigator
  • Have an external wound with excessive or heavy exudate that cannot be controlled during the imaging session. Excessive drainage can obscure external wound features.
Show all 12Show fewer
  • If the patient has a complex external wound:
  • The external wound wraps around a body edge or otherwise cannot be imaged entirely within the visual field of view.
  • From visual assessment, the external wound edges are not definable and/or cannot be clearly distinguished from other conditions near external wound (E.g. breakdown or the deterioration of the surrounding body surfaces due to other conditions such as cancer or other types of ulcers makes determining the edge of the external wound impossible).
  • Have not provided signed informed consent
  • Non-English speaking
  • Subjects in isolation

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Integrative Center for Healing

    Cincinnati, Ohio, 45242

Other trials in United States

About this study

Official title: Scout Overlay-Trace-On-Thermal Feature in a Wound Clinic Setting: A Prospective Study

The purpose of this study is to test and evaluate how well a medical imaging device that takes both visual and thermal pictures of wounds or body surface areas of interest can help collect added information about the wounds or body surface areas of interest in a wound clinic.

Being tested
Scout takes visual and thermal images of external wounds, ImageReview's visual perimeter trace of the external wound, ImageReview's External Wound Trace Overlay, ImageReview's unaffected reference area selected, Adjacent tissue trace of the wound trace overlay
Keywords
wounds, thermal, temperature, periwound, camera, imaging
Medical subject headings
Wounds and Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Scout takes visual and thermal images of external woundsDevice

    Also called Wound Measuring and Monitoring System/WMMS (past)

    All images are taken after the wound has acclimated.

  • ImageReview's visual perimeter trace of the external woundDevice

    Trace is drawn by the study staff using the ImageReview software.

  • ImageReview's External Wound Trace OverlayDevice

    Study staff overlay the trace of the visual external wound's perimeter onto the corresponding thermal image of the external wound.

  • ImageReview's unaffected reference area selectedDevice

    Study Staff select an unaffected reference area of an adjacent body surface.

  • Adjacent tissue trace of the wound trace overlayDevice

    Study staff select an adjacent tissue trace of the wound trace overlay

Study groups in NCT02028390
Study groupRoleWhat they receive
subjects with external woundsExperimentalSubjects with external wounds or body surface areas of interest are imaged visually and thermally with the Scout to trace the wound's perimeter visually and measure thermal variation data as described in the primary outcomes, using the ImageReview software.
Receives: Device: Scout takes visual and thermal images of external wounds; Device: ImageReview's visual perimeter trace of the external wound; Device: ImageReview's External Wound Trace Overlay; Device: ImageReview's unaffected reference area selected; Device: Adjacent tissue trace of the wound trace overlay

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pixel gradient of the thermal wound surface

    Pixel gradient of the thermal wound surface will be measured, with changes documented during regularly scheduled wound care visits for a minimum of two visits and may continue at the discretion of the primary investigator and the subject until the subject no longer qualifies or the study is ended, when 100 subjects are enrolled or the study has completed two years.

    Measured: Weeks 1-104, with week 104 as an estimated time frame maximum, for which changes will be measured and documented

  2. Mean pixel value of the thermal wound surface

    Mean pixel value of the thermal wound surface will be measured, with changes documented during regularly scheduled wound care visits for a minimum of two visits and may continue at the discretion of the primary investigator and the subject until the subject no longer qualifies or the study is ended, when 100 subjects are enrolled or the study has completed two years.

    Measured: Weeks 1-104, with week 104 as an estimated time frame maximum, for which changes will be measured and documented

  3. Mode pixel value of the thermal wound surface

    Mode pixel value of the thermal wound surface will be measured, with changes documented during regularly scheduled wound care visits at the wound clinic for a minimum of two visits and may continue at the discretion of the primary investigator and the subject until the subject no longer qualifies or the study is ended, when 100 subjects are enrolled or the study has completed two years.

    Measured: Weeks 1-104, with week 104 as an estimated time frame maximum, for which changes will be measured and documented

  4. Pixel gradient of the thermal unaffected area of body surface selected

    Pixel gradient of the the thermal unaffected area of body surface selected will be measured, with changes documented during regularly scheduled wound care visits for a minimum of two visits and may continue at the discretion of the primary investigator and the subject until the subject no longer qualifies or the study is ended, when 100 subjects are enrolled or the study has completed two years.

    Measured: Weeks 1-104, with week 104 as an estimated time frame maximum, for which changes will be measured and documented

  5. Highest pixel value of the thermal wound surface

    Highest pixel value of the thermal wound surface will be measured, with changes documented during regularly scheduled wound care visits for a minimum of two visits and may continue at the discretion of the primary investigator and the subject until the subject no longer qualifies or the study is ended, when 100 subjects are enrolled or the study has completed two years.

    Measured: Weeks 1-104, with week 104 as an estimated time frame maximum, for which changes will be measured and documented

  6. Lowest pixel value of the thermal wound surface

    Lowest pixel value of the thermal wound surface will be measured, with changes documented during regularly scheduled wound care visits for a minimum of two visits and may continue at the discretion of the primary investigator and the subject until the subject no longer qualifies or the study is ended, when 100 subjects are enrolled or the study has completed two years.

    Measured: Weeks 1-104, with week 104 as an estimated time frame maximum, for which changes will be measured and documented

  7. Comparison of adjacent tissue trace around the wound bed's surface's relative temperature (Centigrade and Fahrenheit) to the unaffected reference area's relative temperature (Centigrade and Fahrenheit).

    Comparison of adjacent tissue trace around the wound bed's surface's relative temperature (Centigrade and Fahrenheit) to the unaffected reference area's relative temperature (Centigrade and Fahrenheit), with changes documented during regularly scheduled wound care visits for a minimum of two visits and may continue at the discretion of the primary investigator and the subject until the subject no longer qualifies or the study is ended, when 100 subjects are enrolled or the study has completed two years.

    Measured: Weeks 1-104, with week 104 as an estimated time frame maximum, for which changes will be measured and documented

  8. Comparison of wound surface's relative temperature (Centigrade and Fahrenheit) to the unaffected reference area's relative temperature (Centigrade and Fahrenheit).

    Comparison of wound surface's relative temperature (Centigrade and Fahrenheit) to the unaffected reference area's relative temperature (Centigrade and Fahrenheit), with changes documented during regularly scheduled wound care visits for a minimum of two visits and may continue at the discretion of the primary investigator and the subject until the subject no longer qualifies or the study is ended, when 100 subjects are enrolled or the study has completed two years.

    Measured: Weeks 1-104, with week 104 as an estimated time frame maximum, for which changes will be measured and documented

  9. Wound surface's % relative temperature above, below, or equal to the unaffected reference area's temperature

    Wound surface's % relative temperature above, below, or equal to the unaffected reference area's relative temperature, with changes documented during regularly scheduled wound care visits for a minimum of two visits and may continue at the discretion of the primary investigator and the subject until the subject no longer qualifies or the study is ended, when 100 subjects are enrolled or the study has completed two years.

    Measured: Weeks 1-104, with week 104 as an estimated time frame maximum, for which changes will be measured and documented

  10. Adjacent tissue trace's surface % relative temperature above, below, or equal to the unaffected reference area's temperature

    Adjacent tissue trace's surface's % relative temperature above, below, or equal to the unaffected reference area's relative temperature, with changes documented during regularly scheduled wound care visits for a minimum of two visits and may continue at the discretion of the primary investigator and the subject until the subject no longer qualifies or the study is ended, when 100 subjects are enrolled or the study has completed two years.

    Measured: Weeks 1-104, with week 104 as an estimated time frame maximum, for which changes will be measured and documented

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Jan 2014 (estimated)
  2. Study startDec 2013
  3. Primary completionDec 2015
  4. Study completionMar 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
31 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02028390
Sponsor's protocol ID
WV13CL-0008 Revision 02
Status last verified
Nov 2016
First submitted
23 Dec 2013
Last updated
2 Nov 2016
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing Scout takes visual and thermal images of external wounds, ImageReview's visual perimeter trace of the external wound and ImageReview's External Wound Trace Overlay in people with Wounds and Injuries, run by Wound Vision at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 2 Nov 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pixel gradient of the thermal wound surface (time frame: Weeks 1-104, with week 104 as an estimated time frame maximum, for which changes will be measured and documented). The study lists 10 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Nov 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in